The use of ischemia modified albumin as a predictive and prognostic biomarker in patients with non–acetaminophen-induced acute liver failure. Annals of Medical Research, [S. l.], v. 29, n. 8, p. 846–852, 2022. Disponível em: http://annalsmedres.org/index.php/aomr/article/view/4236. Acesso em: 3 apr. 2025.